+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Infection Surveillance Solution Market (2022-2027) by Component, Deployment, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 183 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5684292

Ai-Enabled Clinical Surveillance Can Help Detect Patients That Are At-Risk for a Particular Disease

The Global Infection Surveillance Solution Market is estimated to be USD 724.37 Mn in 2022 and is expected to reach USD 1584.08 Mn by 2027, growing at a CAGR of 16.94%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Infection Surveillance Solution Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Infection Surveillance Solution Market is segmented based on Component, Deployment, End User, and Geography.
  • By Component, the market is classified into Software and Services.
  • By Deployment, the market is classified into On-Cloud and On-Premise.
  • By End User, the market is classified into Hospital, Long-Term Care Facility, and Ambulatory Surgery Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Becton, Dickinson, and Company, Biomérieux SA, Biovigil Healthcare Systems Inc., Cantel Medical Corp, DEB Group Ltd., Ecolab Inc., Epic Systems Corp, Getinge AB, Harris Healthcare Group, Hygreen, Inc., IBM Corp, STERIS PLC, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Infection Surveillance Solution Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Infection Surveillance Solution Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Infection Surveillance Solution Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Infection Surveillance Solution Market

What is the estimated value of the Global Infection Surveillance Solution Market?

The Global Infection Surveillance Solution Market was estimated to be valued at $724.37 Million in 2022.

What is the growth rate of the Global Infection Surveillance Solution Market?

The growth rate of the Global Infection Surveillance Solution Market is 16.9%, with an estimated value of $1584.08 Million by 2027.

What is the forecasted size of the Global Infection Surveillance Solution Market?

The Global Infection Surveillance Solution Market is estimated to be worth $1584.08 Million by 2027.

Who are the key companies in the Global Infection Surveillance Solution Market?

Key companies in the Global Infection Surveillance Solution Market include 3M Company, Advanced Sterilization Products, Atlas Medical Software, Becton, Dickinson, and Company, Biomérieux SA, Biovigil Healthcare Systems Inc., Cantel Medical Corp, Centrak, Inc., Cerner Corp and Ckm Healthcare Inc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Hospital-Acquired Infections
4.1.2 Increasing Adoption of Antimicrobial Stewardship Programs
4.1.3 Growing Geriatric Population and the Increasing Incidence of Chronic Diseases
4.2 Restraints
4.2.1 High Cost of Deployment for Small Healthcare Organizations
4.2.2 Reluctance Among Medical Professionals to Adopt Advanced Healthcare It Solutions
4.3 Opportunities
4.3.1 Increasing Consolidation in the Healthcare Industry
4.3.2 Increasing Demand for Cloud-Based Software Solutions
4.4 Challenges
4.4.1 Limited availability of skilled healthcare professional
4.4.2 Data Security Concerns
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Infection Surveillance Solution Market, By Component
6.1 Introduction
6.2 Software
6.3 Services
6.3.1 Product Support & Maintenance
6.3.2 Implementation Services
6.3.3 Training & Consulting Services
7 Global Infection Surveillance Solution Market, By Deployment
7.1 Introduction
7.2 On-Cloud
7.3 On-Premise
8 Global Infection Surveillance Solution Market, By End User
8.1 Introduction
8.2 Hospital
8.3 Long-Term Care Facility
8.4 Ambulatory Surgery Centers
9 Americas’ Infection Surveillance Solution Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Infection Surveillance Solution Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Infection Surveillance Solution Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Infection Surveillance Solution Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 3M Company
14.2 Advanced Sterilization Products
14.3 Atlas Medical Software
14.4 Becton, Dickinson, and Company
14.5 Biomérieux SA
14.6 Biovigil Healthcare Systems Inc.
14.7 Cantel Medical Corp
14.8 Centrak, Inc.
14.9 Cerner Corp
14.10 Ckm Healthcare Inc.
14.11 DEB Group Ltd.
14.12 Ecolab Inc.
14.13 Epic Systems Corp
14.14 Getinge AB
14.15 Gojo Industries, Inc.
14.16 Harris Healthcare Group
14.17 Hygreen, Inc.
14.18 IBM Corp
14.19 ICNet International Limited
14.20 Medexter Healthcare Gmbh
14.21 Perahealth Inc.
14.22 Premier, Inc.
14.23 RL Solutions
14.24 Rldatix
14.25 STERIS PLC
14.26 Sunquest Information Systems (Roper Tech.)
14.27 Vecna Technologies
14.28 Vigilanz Corp
14.29 Wolters Kluwer N.V.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • 3M Company
  • Advanced Sterilization Products
  • Atlas Medical Software
  • Becton, Dickinson, and Company
  • Biomérieux SA
  • Biovigil Healthcare Systems Inc.
  • Cantel Medical Corp
  • Centrak, Inc.
  • Cerner Corp
  • Ckm Healthcare Inc.
  • DEB Group Ltd.
  • Ecolab Inc.
  • Epic Systems Corp
  • Getinge AB
  • Gojo Industries, Inc.
  • Harris Healthcare Group
  • Hygreen, Inc.
  • IBM Corp
  • ICNet International Limited
  • Medexter Healthcare Gmbh
  • Perahealth Inc.
  • Premier, Inc.
  • RL Solutions
  • Rldatix
  • STERIS PLC
  • Sunquest Information Systems (Subsidiary of Roper Tech.)
  • Vecna Technologies
  • Vigilanz Corp
  • Wolters Kluwer N.V.